1 / 13

Veterinary oncology market analysis

Veterinary oncology market analysis

rishabhCMI
Télécharger la présentation

Veterinary oncology market analysis

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Coherent Market Insights Market Research and Business Consulting Services https://www.coherentmarketinsights.com/ COVID-19 Impact Tracker

  2. VETERINARY ONCOLOGY MARKET ANALYSIS • Veterinary Oncology Market, by Animal Type (Companion Animal (Equine, Canine, and Feline), and Livestock Animal), by Therapy Type (Chemotherapy, Combination Therapy, Immunotherapy, and Targeted Therapy), by Mode of Administration (Oral and Intravenous), by Application (Canine Lymphoma, Osteosarcoma (OSA), Mast Cell Cancer, Melanoma, and Multiple Myeloma), by Distribution Channel (Hospital Pharmacies, Government Agencies, and Retail Pharmacies), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) - Size, Share, Outlook, and Opportunity Analysis, 2019 - 2026

  3. Veterinary oncology is subspecialty of veterinary medicine that deals with the diagnosis and treatment of cancer in animals. With emerging technologies, the use of biotechnology products in veterinary medicines is increasing. Despite the costs that many times accompany the development of novel biotechnological products, recombinant virus vector vaccines, recombinant proteins such as bioactive cytokines and immunotherapeutic allergens, therapeutic antibodies, and oncolytic viruses are the result of advancements in biotechnology for veterinary medicines. The benefits associated with using biotechnology products are large-scale production, reduced costs, long-term action, and multiple antigen vaccines. • Market Dynamics • Increasing prevalence of veterinary cancer is expected to boost the global veterinary oncology market growth during the forecast period. For instance, according to the Veterinary Cancer Society, in 2016, cancer is the leading cause of death in 47% of dogs diagnosed with cancer over the age of 10 years; and 32% of cats, where Feline Leukaemia Virus (FeLV) is one of the leading cause of lymphoma in cats. Moreover, according to the Animal Cancer Foundation in 2015, around 6 million new cancer cases in dogs and cats are recorded, annually, in the U.S., of which one-third of all tumors in dogs are skin tumors, while around 20% are mast cell tumors. • However, adverse effects associated with chemotherapies, immunotherapies, and targeted therapies such as diarrhoea, anorexia, decreased appetite, lethargy, neutropenia, emesis, lameness, severe weight loss, and musculoskeletal disorder are major factors restraining the veterinary oncology market growth.

  4. Key features of the study: • This report provides in-depth analysis of the global veterinary oncology market, market size (US$ Mn), and compound annual growth rate (CAGR %) during the forecast period: 2019 – 2026, considering 2018 as the base year • It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players operating in this market • It profiles key players in the global veterinary oncology market based on the following parameters–company overview, financial performance, product portfolio, geographical presence, distribution strategies, key developments, and strategies • Key players covered as a part of this study include, Zoetis Inc., Elanco, AB Science, BoehringerIngelheim International GmbH, Zenoaq, VetDC, Morphogenesis, Inc., Karyopharm Therapeutics, Inc., Regeneus Ltd., AdvaVet, Inc., and Rhizen Pharmaceutical SA • Insights from this report would allow marketers and management authorities of companies to make informed decision with respect to their future product launch, governmental initiatives, technological up-gradation, market expansion, and marketing tactics • The global veterinary oncology market report caters to various stakeholders in this industry, including investors, product manufacturers, distributors, and suppliers for global veterinary oncology market, research and consulting firms, new entrants, and financial analysts

  5.  Detailed Segmentation: • Global Veterinary Oncology Market, By Animal Type: • Companion Animal • Equine • Canine • Feline • Livestock Animal • Global Veterinary Oncology Market, By Therapy Type: • Chemotherapy • Combination Therapy • Immunotherapy • Targeted Therapy • Global Veterinary Oncology Market, By Mode of Administration: • Oral • Intravenous • Global Veterinary Oncology Market, By Application: • Canine Lymphoma • Osteosarcoma (OSA) • Mast Cell Cancer • Melanoma • Multiple Myeloma • Global Veterinary Oncology Market, By Distribution Channel: • Hospital Pharmacies • Government Agencies • Retail Pharmacies • Global Veterinary Oncology Market, By Region: • North America • By Country: • U.S. • Canada

  6. By Animal Type: • Companion Animal • Equine • Canine • Feline • Livestock Animal • By Therapy Type: • Chemotherapy • Combination Therapy • Immunotherapy • Targeted Therapy • By Mode of Administration: • Oral • Intravenous • By Application: • Canine Lymphoma • Osteosarcoma (OSA) • Mast Cell Cancer • Melanoma • Multiple Myelom

  7. EuropeBy Country: • U.K. • Germany • Italy • Spain • France • Russia • Rest of Europe • By Animal Type: • Companion Animal • Equine • Canine • Feline • Livestock Animal • By Therapy Type: • Chemotherapy • Combination Therapy • Immunotherapy • Targeted Therapy • By Mode of Administration: • Oral • Intravenous

  8. Asia PacificBy Country: • Australia • India • China • Japan • ASEAN • South Korea • Rest of Asia Pacific • By Animal Type: • Companion Animal • Equine • Canine • Feline • Livestock Animal • By Therapy Type: • Chemotherapy • Combination Therapy • Immunotherapy • Targeted Therapy • By Mode of Administration: • Oral • Intravenous

  9. By Application: • Canine Lymphoma • Osteosarcoma (OSA) • Mast Cell Cancer • Melanoma • Multiple Myeloma • By Distribution Channel: • Hospital Pharmacies • Government Agencies • Retail Pharmacies • Latin America • By Country: • Brazil • Mexico • Argentina • Rest of Latin America • By Animal Type: • Companion Animal • Equine • Canine • Feline

  10. Request Sample Report • Request Customization • Download PDF Brochure • Talk to Analyst • Buy Now Reference: https://www.coherentmarketinsights.com/market-insight/veterinary-oncology-market-2995

  11. About Us Coherent Market Insights is a global market intelligence and consulting organization focused on assisting our plethora of clients achieve transformational growth by helping them make critical business decisions. What we provide: • Customized Market Research Services • Industry Analysis Services • Business Consulting Services • Market Intelligence Services • Long term Engagement Model • Country Specific Analysis

  12. Contact Us Mr. Shah Coherent Market Insights Pvt.Ltd. Address: 1001 4th Ave, #3200 Seattle, WA 98154, U.S. Phone: +1-206-701-6702 Email: sales@coherentmarketinsights.com

  13. Thank You! Kindly follow CMI Social Media Profiles for the latest company updates Facebook Linkedin Twitter https://www.coherentmarketinsights.com/

More Related